Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,116 across all filing types
Latest filing 2022-04-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
关于公司控股股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the partial release of pledged shares by the controlling shareholder of the company. It details the number of shares released from pledge, the shareholder's total pledged shares, and reassurances about the absence of risks related to share pledging. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge status, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Major Shareholding Notification (MRQ) or Transaction in Own Shares (POS) because it concerns pledge release rather than share ownership changes or buybacks.
2022-04-14 Chinese
关于转让全资子公司股权的完成公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of a transaction involving the transfer of 100% equity of a wholly-owned subsidiary. It details the board meeting approval, transaction progress, receipt of payment, and completion of the equity transfer. There is no financial report, audit, or detailed financial data presented. The document is a corporate announcement about a capital transaction (equity transfer). This fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through subsidiary equity transfer.
2022-03-31 Chinese
关于股价异动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company regarding abnormal stock price fluctuations over a few trading days. It includes explanations and clarifications about the situation, confirming no undisclosed material information or violations of disclosure rules. The document is short (1242 characters) and focuses on stock price movement and regulatory compliance rather than financial results or detailed reports. It does not contain financial statements or detailed financial data. This type of document fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-03-27 Chinese
关于持股5%以上股东股份减持计划届满的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the reduction in shares, the compliance with relevant laws and regulations, and confirms that the reduction plan has been fully implemented. This type of document is a notification about transactions in the company's own shares by a significant shareholder, which fits the category of 'Transaction in Own Shares'. The document length is 1894 characters, which is typical for such announcements and not a full financial report or regulatory filing. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2022-03-23 Chinese
关于变更签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from a company about the change of its signing certified public accountants for the audit of the 2021 financial report. It details the replacement of one signing auditor with another and confirms that this change will not affect the audit work. The document is short (1004 characters) and does not contain any financial statements or substantive financial data. It is not the audit report itself but an announcement related to audit personnel changes. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and related audit information excluding full annual reports. FY 2021
2022-03-17 Chinese
关于持股5%以上股东股份减持数量过半暨减持超过1%的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the reduction of shares held by a shareholder owning more than 5% of the company. It details the shareholder's shareholding changes, reduction plans, and compliance with relevant regulations. The content focuses on shareholding changes by a major shareholder and does not contain financial statements, earnings data, or management discussion. It is not a full financial report or earnings release but a formal disclosure of a significant shareholder's share reduction. This fits the definition of a Major Shareholding Notification (MRQ). The document length is 4233 characters, which is sufficient for a detailed announcement, not a brief report publication notice or certification. Therefore, the correct classification is MRQ with high confidence.
2022-03-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.